{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T02:24:16Z","timestamp":1782786256953,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-024-01720-3","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T08:02:51Z","timestamp":1727683371000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Insulin resistance and insulin secretory defect among Bangalee PCOS women: a case-control study"],"prefix":"10.1186","volume":"24","author":[{"given":"Jannatul","family":"Nayeem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MM Towhidul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzana","family":"Deeba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahjada","family":"Selim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liaquat","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yearul","family":"Kabir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,30]]},"reference":[{"issue":"1","key":"1720_CR1","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1186\/s12905-022-01983-9","volume":"22","author":"F Bahadori","year":"2022","unstructured":"Bahadori F, Jahanian Sadatmahalleh S, Montazeri A, Nasiri M. Sexuality and psychological well-being in different polycystic ovary syndrome phenotypes compared with healthy controls: a cross-sectional study. BMC Womens Health. 2022;22(1):390. https:\/\/doi.org\/10.1186\/s12905-022-01983-9.","journal-title":"BMC Womens Health"},{"issue":"4","key":"1720_CR2","doi-asserted-by":"publisher","first-page":"261","DOI":"10.4103\/jhrs.JHRS_95_18","volume":"13","author":"R Deswal","year":"2020","unstructured":"Deswal R, Narwal V, Dang A, Pundir CS. The prevalence of polycystic ovary syndrome: a brief systematic review. J Hum Reprod Sci. 2020;13(4):261\u201371. https:\/\/doi.org\/10.4103\/jhrs.JHRS_95_18.","journal-title":"J Hum Reprod Sci"},{"key":"1720_CR3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4103\/jmgims.jmgims_62_19","volume":"25","author":"M Chatterjee","year":"2020","unstructured":"Chatterjee M, Bandyopadhyay SA. Assessment of the prevalence of polycystic ovary syndrome among the college students: a case\u2013control study from Kolkata. J Mahatma Gandhi Inst Med Sci. 2020;25:28\u201332.","journal-title":"J Mahatma Gandhi Inst Med Sci"},{"key":"1720_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1477-7827-9-39","volume":"9","author":"FR Tehrani","year":"2011","unstructured":"Tehrani FR, Simbar M, Tohidi M, Hosseinpanah F, Azizi F. The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study. Reprod Biol Endocrinol. 2011;9:39. https:\/\/doi.org\/10.1186\/1477-7827-9-39.","journal-title":"Reprod Biol Endocrinol"},{"key":"1720_CR5","first-page":"377","volume-title":"Diagnostic criteria for polycystic ovary syndrome: towards a more rational approach. PCOS","author":"JK Zawadzki","year":"1992","unstructured":"Zawadzki JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a more rational approach. PCOS. Boston: Blackwell Scientific; 1992. p. 377\u201384."},{"issue":"1","key":"1720_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"ESHRE Rotterdam","year":"2004","unstructured":"Rotterdam ESHRE, ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41\u20137. https:\/\/doi.org\/10.1093\/humrep\/deh098.","journal-title":"Hum Reprod"},{"issue":"1","key":"1720_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"ESHRE Rotterdam","year":"2004","unstructured":"Rotterdam ESHRE, ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19\u201325. https:\/\/doi.org\/10.1016\/j.fertnstert.2003.10.004.","journal-title":"Fertil Steril"},{"issue":"2","key":"1720_CR8","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","volume":"91","author":"R Azziz","year":"2009","unstructured":"Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. Task Force on the phenotype of the polycystic ovary syndrome of the androgen excess and PCOS Society. The androgen excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91(2):456\u201388. https:\/\/doi.org\/10.1016\/j.fertnstert.2008.06.035.","journal-title":"Fertil Steril"},{"issue":"56","key":"1720_CR9","doi-asserted-by":"publisher","first-page":"96351","DOI":"10.18632\/oncotarget.19180","volume":"8","author":"T Ding","year":"2017","unstructured":"Ding T, Hardiman PJ, Petersen I, Wang FF, Qu F, Baio G. The prevalence of polycystic ovary syndrome in reproductive-aged women of different ethnicity: a systematic review and meta-analysis. Oncotarget. 2017;8(56):96351\u20138. https:\/\/doi.org\/10.18632\/oncotarget.19180.","journal-title":"Oncotarget"},{"issue":"8","key":"1720_CR10","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.steroids.2013.04.006","volume":"78","author":"Y Zhao","year":"2013","unstructured":"Zhao Y, Qiao J. Ethnic differences in the phenotypic expression of polycystic ovary syndrome. Steroids. 2013;78(8):755\u201360. https:\/\/doi.org\/10.1016\/j.steroids.2013.04.006.","journal-title":"Steroids"},{"issue":"2","key":"1720_CR11","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ajog.2017.04.007","volume":"217","author":"JL Chan","year":"2017","unstructured":"Chan JL, Kar S, Vanky E, Morin-Papunen L, Piltonen T, Puurunen J, et al. Racial and ethnic differences in the prevalence of metabolic syndrome and its components of metabolic syndrome in women with polycystic ovary syndrome: a regional cross-sectional study. Am J Obstet Gynecol. 2017;217(2):189. https:\/\/doi.org\/10.1016\/j.ajog.2017.04.007.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"1720_CR12","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1067\/mob.2002.126650","volume":"187","author":"RP Kauffman","year":"2002","unstructured":"Kauffman RP, Baker VM, Dimarino P, Gimpel T, Castracane VD. Polycystic ovarian syndrome and insulin resistance in white and Mexican American women: a comparison of two distinct populations. Am J Obstet Gynecol. 2002;187(5):1362\u20139. https:\/\/doi.org\/10.1067\/mob.2002.126650.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"1720_CR13","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1210\/jc.2005-2430","volume":"91","author":"JC Lo","year":"2006","unstructured":"Lo JC, Feigenbaum SL, Yang J, Pressman AR, Selby JV, Go AS. Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91(4):1357\u201363. https:\/\/doi.org\/10.1210\/jc.2005-2430.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1720_CR14","doi-asserted-by":"publisher","first-page":"987","DOI":"10.3390\/jcm9040987","volume":"9","author":"S Davinelli","year":"2020","unstructured":"Davinelli S, Nicolosi D, Di Cesare C, Scapagnini G, Di Marco R. Targeting metabolic consequences of insulin resistance in polycystic ovary syndrome by D-chiro-inositol and emerging nutraceuticals: a focused review. J Clin Med. 2020;9(4):987. https:\/\/doi.org\/10.3390\/jcm9040987.","journal-title":"J Clin Med"},{"issue":"7","key":"1720_CR15","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.tem.2007.07.003","volume":"18","author":"HF Escobar-Morreale","year":"2007","unstructured":"Escobar-Morreale HF, San Mill\u00e1n JL. Abdominal adiposity and the polycystic ovary syndrome. Trends Endocrinol Metab. 2007;18(7):266\u201372. https:\/\/doi.org\/10.1016\/j.tem.2007.07.003.","journal-title":"Trends Endocrinol Metab"},{"issue":"2","key":"1720_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1365-2265.1990.tb00857.x","volume":"32","author":"DS Kiddy","year":"1990","unstructured":"Kiddy DS, Sharp PS, White DM, Scanlon MF, Mason HD, Bray CS, et al. Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases. Clin Endocrinol (Oxf). 1990;32(2):213\u201320. https:\/\/doi.org\/10.1111\/j.1365-2265.1990.tb00857.x.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"1720_CR17","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1093\/oxfordjournals.humrep.a136243","volume":"10","author":"AH Balen","year":"1995","unstructured":"Balen AH, Conway GS, Kaltsas G, Techatrasak K, Manning PJ, West C, Jacobs HS. Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod. 1995;10(8):2107\u201311. https:\/\/doi.org\/10.1093\/oxfordjournals.humrep.a136243.","journal-title":"Hum Reprod"},{"issue":"7","key":"1720_CR18","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.tem.2007.08.001","volume":"18","author":"HJ Teede","year":"2007","unstructured":"Teede HJ, Hutchison SK, Zoungas S. The management of insulin resistance in polycystic ovary syndrome. Trends Endocrinol Metab. 2007;18(7):273\u20139. https:\/\/doi.org\/10.1016\/j.tem.2007.08.001.","journal-title":"Trends Endocrinol Metab"},{"issue":"7","key":"1720_CR19","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.molmed.2006.05.006","volume":"12","author":"E Diamanti-Kandarakis","year":"2006","unstructured":"Diamanti-Kandarakis E, Papavassiliou AG. Molecular mechanisms of insulin resistance in polycystic ovary syndrome. Trends Mol Med. 2006;12(7):324\u201332. https:\/\/doi.org\/10.1016\/j.molmed.2006.05.006.","journal-title":"Trends Mol Med"},{"issue":"6","key":"1720_CR20","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1016\/j.fertnstert.2004.06.040","volume":"82","author":"D Glintborg","year":"2004","unstructured":"Glintborg D, Henriksen JE, Andersen M, Hagen C, Hangaard J, Rasmussen PE, et al. Prevalence of endocrine diseases and abnormal glucose tolerance tests in 340 caucasian premenopausal women with hirsutism as the referral diagnosis. Fertil Steril. 2004;82(6):1570\u20139. https:\/\/doi.org\/10.1016\/j.fertnstert.2004.06.040.","journal-title":"Fertil Steril"},{"issue":"4","key":"1720_CR21","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3109\/09513590903247873","volume":"26","author":"D Glintborg","year":"2010","unstructured":"Glintborg D, Andersen M. An update on the pathogenesis, inflammation, and metabolism in hirsutism and polycystic ovary syndrome. Gynecol Endocrinol. 2010;26(4):281\u201396. https:\/\/doi.org\/10.3109\/09513590903247873.","journal-title":"Gynecol Endocrinol"},{"issue":"27","key":"1720_CR22","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1056\/NEJM199312303292703","volume":"329","author":"S Lillioja","year":"1993","unstructured":"Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, Knowler WC, Bennett PH, Bogardus C. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima indians. N Engl J Med. 1993;329(27):1988\u201392. https:\/\/doi.org\/10.1056\/NEJM199312303292703.","journal-title":"N Engl J Med"},{"issue":"6","key":"1720_CR23","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1210\/edrv.18.6.0318","volume":"18","author":"A Dunaif","year":"1997","unstructured":"Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997;18(6):774\u2013800. https:\/\/doi.org\/10.1210\/edrv.18.6.0318.","journal-title":"Endocr Rev"},{"issue":"1","key":"1720_CR24","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1210\/jcem.84.1.5393","volume":"84","author":"RS Legro","year":"1999","unstructured":"Legro RS, Kunselman AR, Dodson WC, Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab. 1999;84(1):165\u20139. https:\/\/doi.org\/10.1210\/jcem.84.1.5393.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1720_CR25","doi-asserted-by":"publisher","first-page":"20","DOI":"10.4103\/bjem.bjem_14_22","volume":"2","author":"ABM Kamrul-Hasan","year":"2023","unstructured":"Kamrul-Hasan ABM, Aalpona FTZ, Mustari M, Selim S. Prevalence and characteristics of women with polycystic ovary syndrome in Bangladesh \u2013 a narrative review. Bangladesh J Endocrinol Metab. 2023;2(1):20\u20138. https:\/\/doi.org\/10.4103\/bjem.bjem_14_22.","journal-title":"Bangladesh J Endocrinol Metab."},{"key":"1720_CR26","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3329\/bjog.v34i2.58273","volume":"34","author":"N Begum","year":"2019","unstructured":"Begum N, Yousuf NA, Farooq MS, Chowdhury MA. Ferdous. M Association of impaired glucose tolerance and insulin resistance in women with polycystic ovary syndrome. Bangladesh J Obstet Gynaecol. 2019;34:93\u20138.","journal-title":"Bangladesh J Obstet Gynaecol"},{"key":"1720_CR27","doi-asserted-by":"publisher","first-page":"186","DOI":"10.14740\/jem601","volume":"9","author":"S Shah","year":"2019","unstructured":"Shah S, Banu H, Sultana T, Akhtar N, Begum A, Zamila MB, et al. Increased ratio of total testosterone to dihydrotestosterone may predict an adverse metabolic outcome in polycystic ovary syndrome. J Endocrinol Metab. 2019;9:186\u201392.","journal-title":"J Endocrinol Metab"},{"key":"1720_CR28","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3329\/jbcps.v39i4.55943","volume":"39","author":"S Ishrat","year":"2021","unstructured":"Ishrat S, Hussain M. Prevalence of insulin resistance, dyslipidemia and metabolic syndrome in infertile women with polycystic ovary syndrome. J Bangladesh Coll Physicians Surg. 2021;39:225\u201332.","journal-title":"J Bangladesh Coll Physicians Surg"},{"key":"1720_CR29","first-page":"106","volume":"2","author":"H Banu","year":"2021","unstructured":"Banu H, Shahed-Morshed M, Nazma-Akhtar, Tania-Sultana, Afroza-Begum, Moriom-Zamilla, et al. Total testosterone significantly correlates with insulin resistance in polycystic ovary syndrome. Gynecol Reprod Endocrinol Metab. 2021;2:106\u201311.","journal-title":"Gynecol Reprod Endocrinol Metab"},{"key":"1720_CR30","doi-asserted-by":"publisher","first-page":"96","DOI":"10.31344\/ijhhs.v6i1.383","volume":"6","author":"BM Zamila","year":"2022","unstructured":"Zamila BM, Banu H, Morshed M, Shah S, Begum A, Sultana T, et al. Manifestations of polycystic ovary syndrome are similar regardless of the degree of menstrual cycle variation. Int J Hum Health Sci. 2022;6:96\u2013103.","journal-title":"Int J Hum Health Sci"},{"key":"1720_CR31","first-page":"1","volume":"4","author":"B Tania-Sultana","year":"2018","unstructured":"Tania-Sultana B, Afroza-Begum, et al. Metabolic disorders among phenotypes of polycystic ovary syndrome. Int J Endocrinol Metab Disord. 2018;4:1\u20136.","journal-title":"Int J Endocrinol Metab Disord."},{"key":"1720_CR32","first-page":"770","volume":"23","author":"J Banu","year":"2014","unstructured":"Banu J, Fatima P, Sultana P, Chowdhury MA, Begum N, Anwary SA, et al. Association of infertile patients having polycystic ovarian syndrome with recurrent miscarriage. Mymensingh Med J. 2014;23:770\u20133.","journal-title":"Mymensingh Med J"},{"issue":"4","key":"1720_CR33","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.fertnstert.2006.03.037","volume":"86","author":"RS Legro","year":"2006","unstructured":"Legro RS, Myers ER, Barnhart HX, Carson SA, Diamond MP, Carr B, et al. The pregnancy in polycystic ovary syndrome study: baseline characteristics of the randomized cohort including racial effects. Fertil Steril. 2006;86(4):914\u201333. https:\/\/doi.org\/10.1016\/j.fertnstert.2006.03.037.","journal-title":"Fertil Steril"},{"issue":"1","key":"1720_CR34","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1210\/jc.2004-0229","volume":"90","author":"DA Ehrmann","year":"2005","unstructured":"Ehrmann DA, Kasza K, Azziz R, Legro RS, Ghazzi MN, PCOS\/Troglitazone Study Group. Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005;90(1):66\u201371. https:\/\/doi.org\/10.1210\/jc.2004-0229.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1720_CR35","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.fertnstert.2011.05.002","volume":"96","author":"G Ladson","year":"2011","unstructured":"Ladson G, Dodson WC, Sweet SD, Archibong AE, Kunselman AR, Demers LM, Williams NI, Coney P, Legro RS. Racial influence on the polycystic ovary syndrome phenotype: a black and white case-control study. Fertil Steril. 2011;96(1):224-e2292. https:\/\/doi.org\/10.1016\/j.fertnstert.2011.05.002.","journal-title":"Fertil Steril"},{"issue":"4","key":"1720_CR36","first-page":"419","volume":"29","author":"X Li","year":"2004","unstructured":"Li X, Zhou ZG, Qi HY, Chen XY, Huang G. [Replacement of insulin by fasting C-peptide in modified homeostasis model assessment to evaluate insulin resistance and islet beta cell function]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2004;29(4):419\u201323 Chinese.","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"issue":"1","key":"1720_CR37","doi-asserted-by":"publisher","first-page":"E15","DOI":"10.1152\/ajpendo.00645.2007","volume":"294","author":"R Muniyappa","year":"2008","unstructured":"Muniyappa R, Lee S, Chen H, Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab. 2008;294(1):E15-26. https:\/\/doi.org\/10.1152\/ajpendo.00645.2007.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"12","key":"1720_CR38","doi-asserted-by":"publisher","first-page":"e32351","DOI":"10.7759\/cureus.32351","volume":"14","author":"MD Bharali","year":"2022","unstructured":"Bharali MD, Rajendran R, Goswami J, Singal K, Rajendran V. Prevalence of polycystic ovarian syndrome in India: a systematic review and Meta-analysis. Cureus. 2022;14(12):e32351. https:\/\/doi.org\/10.7759\/cureus.32351.","journal-title":"Cureus"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-024-01720-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-024-01720-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-024-01720-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T08:05:00Z","timestamp":1727683500000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-024-01720-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,30]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1720"],"URL":"https:\/\/doi.org\/10.1186\/s12902-024-01720-3","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,30]]},"assertion":[{"value":"28 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Research Ethics Committee of the Department of Biochemistry and Molecular Biology, University of Dhaka, Dhaka, Bangladesh, reviewed and approved the study protocol (BMBDU-ERC\/EC\/09\/20). All women were informed in the local language about the project and fulfilled the written informed consent before participating in the study. In cases of women below the age of 16 years, informed consent to participate was obtained from the parents\/ legal guardians of the participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"207"}}